From Specialty Pharmacy News - Diplomat Pharmacy, Inc. said Feb. 1 that it had finalized its deal for specialty pharmacy and infusion services company Affinity Biotech, Inc. The purchase should strengthen Diplomat’s growing presence within the specialty infusion space, it said. Diplomat paid $16 million for Affinity, which had an estimated $27 million in revenues last year. Affinity provides treatments and services for people with hemophilia and has locations in New York and Houston. Read more
From Specialty Pharmacy News - Although the FDA approved fewer novel new therapies last year than it did in 2015, the specialty drug pipeline remains strong. This new year should see approvals of products in areas that already have multiple competitors, such as anti-inflammatory conditions and multiple sclerosis, as well as treatments for conditions sorely in need of ones, such as tardive dyskinesia (TD) and non-alcoholic steatohepatitis (NASH). Read more
From Drug Benefit News - Although accountable care organizations (ACOs) are a relatively new group of stakeholders within the health care industry, they are helping drive a more value-focused approach across the landscape. And although this team-based strategy continues to grow in use, as costs for and utilization of prescription medications continue to increase, it would only help these organizations to incorporate more pharmacy-focused strategies, according to a recent report from the Pharmacy Benefit Management… Read more
Check out all of the benefits, sample issues & more!